Chinese regulators pen requirements for COVID-19 vaccine approval—and they're stricter than the FDA's

Drugmakers from China and the U.S. are among the frontrunners in COVID-19 vaccine development, and how regulators in those two countries decide to deem a product approvable could set the standard for the rest to come.

Weeks after the FDA rolled out its standards for green-lighting COVID-19 vaccines, its Chinese counterpart Friday released guidance (Chinese) with some similar criteria.